Cite
HARVARD Citation
Calabrese, A. et al. (2019). Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence. European journal of endocrinology. 180 (6), pp. 387-396. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Calabrese, A. et al. (2019). Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence. European journal of endocrinology. 180 (6), pp. 387-396. [Online].